News

As some evidence suggests that falling oestrogen levels could leave older women more at risk from Covid-19, Dr Louise Newson talks to The Guardian in this article exploring why the link between the menopause and Covid needs to be investigated. 

Australian postmenopausal women will now have access to a medically prescribed, clinically effective testosterone formulation which meets the requisite quality and safety standards for registration for the management of hypoactive sexual desire dysfunction (HSDD).

Dr Verity Biggs, GP with special interest in menopause here at Newson Health, recently joined West Mercia Police for a 'Let's Talk Menopause' webinar that was attended by 260 police colleagues from all over the UK.

Dr Louise Newson and Dr Mark Coombe of FourteenFish recently recorded this webinar, aimed at giving healthcare professionals the confidence and knowledge to assess and prescribe HRT to perimenopausal and menopausal women.

The group of people that most commonly experience Long Covid is women in their 50s. Dr Louise Newson has created this questionnaire for women who have been diagnosed with Long Covid to help with future research into this important area. 

Research has shown that a woman's biological age can increase by up to 30% during the perimenopausal period, with the potential for her body to age significantly during this time of life.

Midlife wellness warrior, Liz Earle MBE, recently recorded a special episode of the Liz Earle Wellbeing Show with lead researcher, Dr Yana Vinogradova, with the aim of tackling recent inaccuracies in the press regarding HRT and breast cancer.

Menopause Specialist and GP, Dr Louise Newson, has created two brand-new, exclusive pay-to-view videos containing evidence-based information and advice regarding the perimenopause and menopause to help kick-start The Menopause Charity.

Dr Louise Newson has launched an explanatory video describing her journey into, and passion for improving the world of menopause health.

An observational study has shown that the risk of breast cancer with some types of HRT is actually lower than the previous study reported in the Lancet just over one year ago.